Paper1987490
Man-made antibodies.
Winter G and 1 other. Nature, 1991. Cited by 780 papers, by iCite.
Cite this record
ConductScience Library. Man-made antibodies. Papers, record 1987490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1987490
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Genetic Engineering | Major topic |
| Animals | |
| Antibody Diversity | |
| Antigens | |
| Binding Sites, Antibody | |
| Gene Rearrangement | |
| Genes, Immunoglobulin | |
| Humans | |
| Hybridomas | |
| Immunization | |
| Immunoglobulin Variable Region | |
| Macromolecular Substances | |
| Mice | |
| Molecular Structure | |
| Mutagenesis | |
| Protein Conformation | |
| Rats |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2687698 | Conformations of immunoglobulin hypervariable regions. | Nature | 1989 | https://conductscience.org/library/papers/2687698 | PubMed |
| 2 | 2697647 | Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli. | Gene | 1989 | https://conductscience.org/library/papers/2697647 | PubMed |
| 3 | 2423326 | Modelling of the combining sites of three anti-lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope. | EMBO J | 1986 | https://conductscience.org/library/papers/2423326 | PubMed |
| 4 | 3020687 | Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. | Science | 1986 | https://conductscience.org/library/papers/3020687 | PubMed |
| 5 | 3058579 | The dynamic nature of the antibody repertoire. | Immunol Rev | 1988 | https://conductscience.org/library/papers/3058579 | PubMed |
| 6 | 3724461 | Bispecific monoclonal antibodies from hybrid hybridomas. | Methods Enzymol | 1986 | https://conductscience.org/library/papers/3724461 | PubMed |
| 7 | 2971269 | The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. | Science | 1988 | https://conductscience.org/library/papers/2971269 | PubMed |
| 8 | 10872333 | Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. | EMBO J | 1983 | https://conductscience.org/library/papers/10872333 | PubMed |
| 9 | 3136320 | A new means of inducibly inactivating a cellular protein. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/3136320 | PubMed |
| 10 | 2498664 | A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. | Nature | 1989 | https://conductscience.org/library/papers/2498664 | PubMed |
| 11 | 6504141 | Somatic mutation and the maturation of immune response to 2-phenyl oxazolone. | Nature | 1984 | https://conductscience.org/library/papers/6504141 | PubMed |
| 12 | 6765233 | Immunoglobulin V region variants in hybridoma cells. I. Isolation of a variant with altered idiotypic and antigen binding specificity. | EMBO J | 1982 | https://conductscience.org/library/papers/6765233 | PubMed |
| 13 | 3545451 | Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. | Cancer Res | 1987 | https://conductscience.org/library/papers/3545451 | PubMed |
| 14 | 3655369 | Immunoglobulin chain recombination among antidigoxin antibodies by hybridoma-hybridoma fusion. | J Immunol | 1987 | https://conductscience.org/library/papers/3655369 | PubMed |
| 15 | 1970124 | Biological properties of a CD4 immunoadhesin. | Nature | 1990 | https://conductscience.org/library/papers/1970124 | PubMed |
| 16 | 2629848 | Direct cDNA cloning of the rearranged immunoglobulin variable region. | Biotechniques | 1989 | https://conductscience.org/library/papers/2629848 | PubMed |
| 17 | 2451287 | Reshaping human antibodies: grafting an antilysozyme activity. | Science | 1988 | https://conductscience.org/library/papers/2451287 | PubMed |
| 18 | 2247164 | Phage antibodies: filamentous phage displaying antibody variable domains. | Nature | 1990 | https://conductscience.org/library/papers/2247164 | PubMed |
| 19 | 3787262 | Selective chemical catalysis by an antibody. | Science | 1986 | https://conductscience.org/library/papers/3787262 | PubMed |
| 20 | 3298009 | Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development. | Immunol Rev | 1987 | https://conductscience.org/library/papers/3298009 | PubMed |
Cited by189
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 780 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42466865 | Protein engineering: status report. | Protein Eng Des Sel | 2026 | https://conductscience.org/library/papers/42466865 | PubMed |
| 41627946 | Tiny tools closing the gap: nanobodies in research and therapy. | Function (Oxf) | 2026 | https://conductscience.org/library/papers/41627946 | PubMed |
| 41309056 | Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display. | J Biomed Res | 2026 | https://conductscience.org/library/papers/41309056 | PubMed |
| 41257876 | Identification of internalizing ScFvs for EGFR inhibition and apoptosis induction in cholangiocarcinoma cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/41257876 | PubMed |
| 41219972 | Technological advancements in antibody-based therapeutics for treatment of diseases. | J Biomed Sci | 2025 | https://conductscience.org/library/papers/41219972 | PubMed |
| 40687289 | Expression and functional characterization of an anti-CD22 scFv targeting B-cell malignancies. | Res Pharm Sci | 2025 | https://conductscience.org/library/papers/40687289 | PubMed |
| 39358613 | Therapeutic antibodies in oncology: an immunopharmacological overview. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/39358613 | PubMed |
| 38940338 | Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review). | Mol Med Rep | 2024 | https://conductscience.org/library/papers/38940338 | PubMed |
| 38607316 | A systemic approach to identifying sequence frameworks that decrease mAb production in a transient Chinese hamster ovary cell expression system. | Biotechnol Prog | 2024 | https://conductscience.org/library/papers/38607316 | PubMed |
| 38322331 | Evolution of chemistry and selection technology for DNA-encoded library. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38322331 | PubMed |
| 37876265 | A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies. | MAbs | 2023 | https://conductscience.org/library/papers/37876265 | PubMed |
| 37850148 | What Have We Learned from Design of Function in Large Proteins? | Biodes Res | 2022 | https://conductscience.org/library/papers/37850148 | PubMed |
| 37679638 | Biomarker Discovery by ORFeome Phage Display. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37679638 | PubMed |
| 37679624 | Antibody Selection in Solution Using Magnetic Beads. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37679624 | PubMed |
| 37371712 | Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371712 | PubMed |
| 36829616 | Bioengineering of Antibody Fragments: Challenges and Opportunities. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/36829616 | PubMed |
| 36451227 | Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases-RA as a role model. | Inflamm Regen | 2022 | https://conductscience.org/library/papers/36451227 | PubMed |
| 36346588 | Molecular Dynamics Methods for Antibody Design. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36346588 | PubMed |
| 35492397 | Hybridoma technology: is it still useful? | Curr Res Immunol | 2021 | https://conductscience.org/library/papers/35492397 | PubMed |
| 34805784 | De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist. | iScience | 2021 | https://conductscience.org/library/papers/34805784 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1987490
GET https://conductscience.org/api/papers/v1/1987490/references?page=2